These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17408248)

  • 21. DNA minor groove adducts formed by a platinum-acridine conjugate inhibit association of tata-binding protein with its cognate sequence.
    Budiman ME; Bierbach U; Alexander RW
    Biochemistry; 2005 Aug; 44(33):11262-8. PubMed ID: 16101310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro anticancer activities and optical imaging of novel intercalative non-cisplatin conjugates.
    Gao J; Woolley FR; Zingaro RA
    J Med Chem; 2005 Nov; 48(23):7192-7. PubMed ID: 16279777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, in vitro cytotoxic and antiviral activity of cis-[Pt(R(-) and S(+)-2-alpha-hydroxybenzylbenzimidazole)2Cl2] complexes.
    Gökçe M; Utku S; Gür S; Ozkul A; Gümüş F
    Eur J Med Chem; 2005 Feb; 40(2):135-41. PubMed ID: 15694648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enantiomerically pure [1, 2-diamino-1-(4-fluorophenyl)butane]platinum(II) complexes: synthesis and antitumor activity against MCF-7 and MDA-MB 231 breast cancer and LnCaP/FGC prostate cancer cell lines.
    Dullin A; Dufrasne F; Gelbcke M; Gust R
    Arch Pharm (Weinheim); 2004 Dec; 337(12):654-67. PubMed ID: 15597399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, characterization and antiproliferative studies of the enantiomers of cis-[(1,2-camphordiamine)dichloro]platinum(II) complexes.
    Montaña AM; Bernal FJ; Lorenzo J; Farnós C; Batalla C; Prieto MJ; Moreno V; Avilés FX; Mesas JM; Alegre MT
    Bioorg Med Chem; 2008 Feb; 16(4):1721-37. PubMed ID: 18036822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
    Coley HM; Sarju J; Wagner G
    J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mono- and polynuclear [alkylamine]platinum(II) complexes of [1,2-bis(4-fluorophenyl)ethylenediamine]platinum(II): synthesis and investigations on cytotoxicity, cellular distribution, and DNA and protein binding.
    Kapp T; Dullin A; Gust R
    J Med Chem; 2006 Feb; 49(3):1182-90. PubMed ID: 16451082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, characterization and antitumor activity of new type binuclear platinum(II) complexes.
    Zhang J; Liu L; Gong Y; Zheng X; Yang M; Cui J; Shen S
    Eur J Med Chem; 2009 May; 44(5):2322-7. PubMed ID: 18524422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
    Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
    J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, DNA-binding affinity and cytotoxicity of the dinuclear platinum(II) complexes with berenil and amines ligands.
    Bielawski K; Bielawska A; Popławska B; Bołkun-Skórnicka U
    Acta Pol Pharm; 2008; 65(3):363-70. PubMed ID: 18646556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bis(acridinylthiourea)platinum(II) complexes: synthesis, DNA affinity, and biological activity in glioblastoma cells.
    Augustus TM; Anderson J; Hess SM; Bierbach U
    Bioorg Med Chem Lett; 2003 Mar; 13(5):855-8. PubMed ID: 12617907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platinum complexes can inhibit matrix metalloproteinase activity: platinum-diethyl[(methylsulfinyl)methyl]phosphonate complexes as inhibitors of matrix metalloproteinases 2, 3, 9, and 12.
    Sasanelli R; Boccarelli A; Giordano D; Laforgia M; Arnesano F; Natile G; Cardellicchio C; Capozzi MA; Coluccia M
    J Med Chem; 2007 Jul; 50(15):3434-41. PubMed ID: 17583333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and in vitro antiproliferative activity of platinum(II) complexes with N-monoalkyl 1R,2R-diaminocyclohexane as ligands.
    Sun Y; Liu F; Gou S; Cheng L; Fang L; Yin R
    Eur J Med Chem; 2012 Sep; 55():297-306. PubMed ID: 22867527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor platinum(II) complexes of N-monoalkyl-1R, 2R-diaminocyclohexane derivatives with alkyl groups as hindrance.
    Sun Y; Yin R; Gou S; Zhaojian
    J Inorg Biochem; 2012 Jul; 112():68-76. PubMed ID: 22561544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair.
    Kostrhunova H; Malina J; Pickard AJ; Stepankova J; Vojtiskova M; Kasparkova J; Muchova T; Rohlfing ML; Bierbach U; Brabec V
    Mol Pharm; 2011 Oct; 8(5):1941-54. PubMed ID: 21806015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metal-intercalator-mediated self-association and one-dimensional aggregation in the structure of the excised major DNA adduct of a platinum-acridine agent.
    Baruah H; Day CS; Wright MW; Bierbach U
    J Am Chem Soc; 2004 Apr; 126(14):4492-3. PubMed ID: 15070347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and activity of a trinuclear platinum complex: [{trans-PtCl(NH3)2}2mu-{trans-Pt(3-hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in ovarian cancer cell lines.
    Tayyem H; Huq F; Yu JQ; Beale P; Fisher K
    ChemMedChem; 2008 Jan; 3(1):145-51. PubMed ID: 17963210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thermally inert metal ammines as light-inducible DNA-targeted agents. Synthesis, photochemistry, and photobiology of a prototypical rhodium(III)-intercalator conjugate.
    Barry CG; Turney EC; Day CS; Saluta G; Kucera GL; Bierbach U
    Inorg Chem; 2002 Dec; 41(26):7159-69. PubMed ID: 12495358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and structure-activity relationship of novel antitumoral platinum xanthate complexes.
    Friebolin W; Schilling G; Zöller M; Amtmann E
    J Med Chem; 2004 Apr; 47(9):2256-63. PubMed ID: 15084124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A non-crosslinking platinum-acridine hybrid agent shows enhanced cytotoxicity compared to clinical BCNU and cisplatin in glioblastoma cells.
    Hess SM; Anderson JG; Bierbach U
    Bioorg Med Chem Lett; 2005 Jan; 15(2):443-6. PubMed ID: 15603970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.